Trademark: 97515693
Word
APDEYA
Status Date
Monday, September 9, 2024
Filing Date
Friday, July 22, 2022
Published for Opposition
Tuesday, June 13, 2023
Abandoned Date
Monday, September 9, 2024
5 Pharmaceutical preparations for the treatment of hematological, nephrological, autoimmune, immunological, ocular, neurological and inflammatory related diseases and disorders
The wording APDEYA has no meaning in a foreign language.
Aug 15, 2022
New Application Office Supplied Data Entered
Jul 27, 2022
New Application Entered
May 9, 2023
Assigned To Examiner
May 9, 2023
Approved For Pub - Principal Register
May 24, 2023
Notification Of Notice Of Publication E-Mailed
Jun 13, 2023
Published For Opposition
Jun 13, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 9, 2024
Sou Teas Extension Received
Jan 9, 2024
Sou Extension 1 Granted
Aug 8, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 9, 2024
Sou Extension 1 Filed
Jan 11, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 11, 2024
Teas Change Of Correspondence Received
Apr 11, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 11, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 24, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 24, 2024
Teas Change Of Correspondence Received
Sep 9, 2024
Abandonment - No Use Statement Filed
Sep 9, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
May 24, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Trademark Alertz updated from USPTO on 2030-01-24
